TRIN Stock Analysis: Trinity Capital | NYSE
Asset Management | NYSE, USA | Market Cap: 1.593m USD | 12M Return: 28.6% | US8964423086 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 16.2M
EPS Trend: -79.8%
Qual. Beats: 0
Rev. Trend: 97.3%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 5.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Trinity Capital Inc. (NYSE: TRIN) is a business development company (BDC) founded in 2008 and headquartered in Phoenix, Arizona, with additional offices in California. The firm provides financing solutions including term loans, equipment financing, and private equity-related investments, organized across five verticals: tech lending, equipment financing, life sciences, warehouse lending, and sponsor finance.
Operating on an industry-agnostic basis, Trinity Capital invests in growth-stage companies across a diverse range of sectors, including aerospace, software, clean technology, energy, life sciences, semiconductors, robotics, transportation, and consumer and retail. The company went public on the NYSE in January 2021 and is classified within the Financials sector under Asset Management & Custody Banks.
As a BDC, Trinity Capital operates under the Investment Company Act of 1940, a regulatory framework that requires such entities to distribute the majority of their taxable earnings to shareholders while primarily lending to or investing in privately held or thinly traded U.S. middle-market companies. The firms focus on private credit positions it within an asset class that has expanded as borrowers increasingly seek financing alternatives outside of traditional banking channels.
- Net interest margin expands as floating-rate loans reprice higher
- Origination volume growth drives net investment income higher
- Credit quality deterioration in tech and life sciences portfolio
| Net Income: 167.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.08 > 0.02 and ΔFCF/TA 11.89 > 1.0 |
| NWC/Revenue: 0.41% < 20% (prev 3.29%; Δ -2.88% < -1%) |
| CFO/TA -0.08 > 3% & CFO -215.8m > Net Income 167.8m |
| Net Debt (1.48b) to EBITDA (235.5m): 6.27 < 3 |
| Current Ratio: 1.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (90.5m) vs 12m ago 37.25% < -2% |
| Gross Margin: 84.15% > 18% (prev 75.81%; Δ 8.34% > 0.5%) |
| Asset Turnover: 11.81% > 50% (prev 12.52%; Δ -0.71% > 0%) |
| Interest Coverage Ratio: 2.51 > 6 (EBIT TTM 235.5m / Interest Expense TTM 93.7m) |
| A: 0.00 (Total Current Assets 41.4m - Total Current Liabilities 40.3m) / Total Assets 2.81b |
| B: -0.01 (Retained Earnings -21.0m / Total Assets 2.81b) |
| C: 0.10 (EBIT TTM 235.5m / Avg Total Assets 2.43b) |
| D: 0.82 (Book Value of Equity 1.27b / Total Liabilities 1.54b) |
| Altman-Z'' = 1.50 = BB |
As of September 27, 2026, the stock is trading at USD 17.66 with a total of 630,789 shares traded. Over the past week, the price has changed by +0.17%, over one month by -4.66%, over three months by +7.51% and over the past year by +28.62%.
Current recommended Stop Loss: 16.90 (which is 4.3% or 2.3 ATR below the current price).
Trinity Capital has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy TRIN.
- StrongBuy: 6
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 18.5 | 4.8% |
P/E Trailing = 10.1839
P/E Forward = 8.3542
P/S = 5.3601
P/B = 1.3178
P/EG = 5.1395
Revenue TTM = 286.4m USD
EBIT TTM = 235.5m USD
EBITDA TTM = 235.5m USD
Long Term Debt = unknown (none)
Short Term Debt = 1.72m USD (from shortTermDebt, last fiscal year)
Debt = 1.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.48b USD (calculated: Debt 1.50b - CCE 22.2m)
Enterprise Value = 3.07b USD (1.59b + Debt 1.50b - CCE 22.2m)
Interest Coverage Ratio = 2.51 (Ebit TTM 235.5m / Interest Expense TTM 93.7m)
EV/FCF = -14.18x (Enterprise Value 3.07b / FCF TTM -216.5m)
FCF Yield = -7.05% (FCF TTM -216.5m / Enterprise Value 3.07b)
FCF Margin = -75.61% (FCF TTM -216.5m / Revenue TTM 286.4m)
Net Margin = 58.60% (Net Income TTM 167.8m / Revenue TTM 286.4m)
Gross Margin = 84.15% ((Revenue TTM 286.4m - Cost of Revenue TTM 45.4m) / Revenue TTM)
Gross Margin QoQ = 85.62% (prev 79.27%)
Tobins Q-Ratio = 1.09 (Enterprise Value 3.07b / Total Assets 2.81b)
Interest Expense / Debt = 6.26% (Interest Expense 93.7m / Debt 1.50b)
Taxrate = 1.79% (3.03m / 169.1m)
NOPAT = 231.3m (EBIT 235.5m * (1 - 1.79%))
Current Ratio = 1.03 (Total Current Assets 41.4m / Total Current Liabilities 40.3m)
Debt / Equity = 1.18 (Debt 1.50b / totalStockholderEquity, last quarter 1.27b)
Debt / EBITDA = 6.27 (Net Debt 1.48b / EBITDA 235.5m)
Debt / FCF = -6.82 (negative FCF - burning cash) (Net Debt 1.48b / FCF TTM -216.5m)
Total Stockholder Equity = 1.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.92% (Net Income 167.8m / Total Assets 2.81b)
RoE = 14.83% (Net Income TTM 167.8m / Total Stockholder Equity 1.13b)
RoCE = 8.52% (EBIT 235.5m / Capital Employed (Total Assets 2.81b - Current Liab 40.3m))
RoIC = 8.40% (NOPAT 231.3m / Invested Capital 2.75b)
WACC = 7.08% (E(1.59b)/V(3.09b) * Re(7.96%) + D(1.50b)/V(3.09b) * Rd(6.26%) * (1-Tc(0.02)))
Discount Rate = 7.96% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 98.02 | Cagr: 29.47%
[DCF] Fair Price = unknown (Cash Flow -216.5m)
EPS Correlation: -79.77 | EPS CAGR: -1.86% | SUE: -0.70 | # QB: 0
Revenue Correlation: 97.28 | Revenue CAGR: 28.06% | SUE: -0.22 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.52 | Chg30d=-0.63% | Revisions=-44% | Analysts=9
EPS current Year (2026-12-31): EPS=2.08 | Chg30d=-0.55% | Revisions=-44% | GrowthEPS=+0.0% | GrowthRev=+25.2%
EPS next Year (2027-12-31): EPS=2.11 | Chg30d=+0.91% | Revisions=+22% | GrowthEPS=+1.3% | GrowthRev=+13.5%
[Analyst] Revisions Ratio: -29% (up=6, down=12)